blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4301758

EP4301758 - SYNTHETIC METHODS AND INTERMEDIATES FOR PRODUCING COMPOUNDS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  08.12.2023
Database last updated on 03.10.2024
FormerThe international publication has been made
Status updated on  09.09.2022
Formerunknown
Status updated on  30.03.2022
Most recent event   Tooltip10.05.2024Change: Validation statespublished on 12.06.2024  [2024/24]
10.05.2024Change - extension statespublished on 12.06.2024  [2024/24]
Applicant(s)For all designated states
Blueprint Medicines Corporation
45 Sidney Street
Cambridge, MA 02139 / US
[2024/02]
Inventor(s)01 / LEE, Christopher
Cambridge, MA 02139 / US
02 / LI, Hui
Cambridge, MA 02139 / US
03 / DIKER, Khalid
60340 Saint Leu d'Esserent / FR
04 / TOURNADE, Baptiste
60340 Saint Leu d'Esserent / FR
05 / CAILLOT, Gilles
60340 Saint Leu d'Esserent / FR
06 / WAGNER, Andreas
5605 Dottikon / CH
07 / HEINRICH, Brian
Cambridge, MA 02139 / US
 [2024/02]
Representative(s)Haile, Alison Victoria, et al
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[2024/02]
Application number, filing date22711793.403.03.2022
[2024/02]
WO2022US18692
Priority number, dateUS202163155947P03.03.2021         Original published format: US 202163155947 P
[2024/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022187477
Date:09.09.2022
Language:EN
[2022/36]
Type: A1 Application with search report 
No.:EP4301758
Date:10.01.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 09.09.2022 takes the place of the publication of the European patent application.
[2024/02]
Search report(s)International search report - published on:EP09.09.2022
ClassificationIPC:C07D487/04
[2024/02]
CPC:
C07D487/04 (EP,IL,KR,US); A61K31/53 (KR); Y02P20/55 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/02]
TitleGerman:SYNTHETISCHE VERFAHREN UND ZWISCHENPRODUKTE ZUR HERSTELLUNG VON VERBINDUNGEN ZUR BEHANDLUNG VON KIT- UND PDGFRA-VERMITTELTEN ERKRANKUNGEN[2024/02]
English:SYNTHETIC METHODS AND INTERMEDIATES FOR PRODUCING COMPOUNDS FOR TREATING KIT- AND PDGFRA-MEDIATED DISEASES[2024/02]
French:PROCÉDÉS SYNTHÉTIQUES ET INTERMÉDIAIRES POUR LA PRODUCTION DE COMPOSÉS POUR TRAITER DES MALADIES MÉDIÉES PAR KIT ET PDGFRA[2024/02]
Entry into regional phase28.09.2023National basic fee paid 
28.09.2023Designation fee(s) paid 
28.09.2023Examination fee paid 
Examination procedure28.09.2023Examination requested  [2024/02]
28.09.2023Date on which the examining division has become responsible
22.04.2024Amendment by applicant (claims and/or description)
Fees paidRenewal fee
03.01.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[IDY]WO2020210293  (BLUEPRINT MEDICINES CORP [US]);
by applicantWO2020210293
 WO2020210669
 US10829493
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.